<DOC>
	<DOCNO>NCT01859078</DOCNO>
	<brief_summary>The purpose study determine effect baricitinib level digoxin blood stream long take body remove digoxin . This study also look safe well-tolerated baricitinib give time digoxin healthy participant . This study last approximately 3-4 week .</brief_summary>
	<brief_title>A Drug Drug Interaction ( DDI ) Study Baricitinib ( LY3009104 ) Digoxin Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<criteria>Women childbearing potential Menopausal woman Have body mass index 18.0 29.0 kilogram per square meter ( kg/m^2 ) Women lactate Have previously complete withdrawn study study investigate baricitinib Currently enrol , complete discontinue within last 90 day clinical trial involve investigational product Have pulse rate le 50 beat per minute ( bpm ) screen Have current recent history ( le 30 day prior screen and/or less 45 day prior Day 1 ) clinically significant bacterial , fungal , parasitic , viral ( include rhinopharyngitis ) , mycobacterial infection Have absolute neutrophil count less 2000 cells/microliter ( 2 Ã— 10^9/liter ) screen Day 1 Show evidence human immunodeficiency virus ( HIV ) infection and/or positive human HIV antibody Have expose live vaccine within 12 week prior first dose expect need/receive live vaccine Intend use overthecounter prescription medication and/or herbal supplement within 14 day prior dose study Have use intend use drug substance know substrate , inducer , inhibitor Pglycoprotein ( Pgp ) within 30 day prior dose throughout study Have symptomatic herpes zoster herpes simplex infection within 90 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>